Viral Related Tools against SARS-CoV-2

Area of Science:

• Virology
• Biotechnology
• Infectious Diseases

Background:

• The emergence of COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 has necessitated rapid scientific innovation.
• The global health crisis prompted a redirection of research efforts towards combating the virus.

Purpose of the Study:

• To summarize recent advancements in virus-based therapies and diagnostics for COVID-19.
• To review the application of viral-vector vaccines, bacteriophages, and CRISPR-Cas technology in addressing the pandemic.

Main Methods:

• Review of current research on viral-vector vaccines in clinical and pre-clinical development.
• Analysis of studies utilizing bacteriophages for antibody identification and potential therapeutic applications against viral diseases.
• Examination of CRISPR-Cas technology for rapid COVID-19 diagnostics and therapeutic strategies.

Main Results:

• Viral-vector vaccines are progressing through clinical and pre-clinical trials.
• Bacteriophages show promise in identifying SARS-CoV-2 specific antibodies and as potential antiviral treatments.
• CRISPR-Cas technology offers a pathway for precise and rapid COVID-19 diagnosis and potential therapeutic interventions.

Conclusions:

• Innovative viral-based strategies, including vaccines, bacteriophages, and CRISPR-Cas technology, are crucial in the fight against COVID-19.
• These technologies hold significant potential for both diagnosing and treating SARS-CoV-2 infections.
• Continued research and development in these areas are vital for managing the ongoing pandemic and future viral threats.